Furthermore, similar to PPAR-α, it has to be considered PPAR-γ variants, considering that Pro12Ala and C1431T polymorphisms alter the susceptibility to hepatic steatosis, lobular inflammation, and fibrosis in humans with NAFLD. Here, PPARG is linked to Hepatic steatosis.